Offer - Urjas Oil for just ₹ 1 X
Intimacy Plus 0.03 mg/0.15 mg Tablet is a prescription medicine that is available as a Tablet. Secondary and off-label uses of Intimacy Plus 0.03 mg/0.15 mg Tablet have also been mentioned below.
The optimal dosage of Intimacy Plus 0.03 mg/0.15 mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Intimacy Plus 0.03 mg/0.15 mg Tablet as well, which are listed below. Normally, these side effects of Intimacy Plus 0.03 mg/0.15 mg Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, Intimacy Plus 0.03 mg/0.15 mg Tablet's effect is Severe during pregnancy and Moderate for lactating mothers. Warnings related to Intimacy Plus 0.03 mg/0.15 mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Intimacy Plus 0.03 mg/0.15 mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Intimacy Plus 0.03 mg/0.15 mg Tablet in conditions like High Blood Pressure, Hypercalcemia, Heart Disease. The section on Intimacy Plus 0.03 mg/0.15 mg Tablet contraindications lists all such conditions.
Besides this, Intimacy Plus 0.03 mg/0.15 mg Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Intimacy Plus 0.03 mg/0.15 mg Tablet is considered not safe while driving, and is not addictive.
Intimacy Plus 0.03 mg/0.15 mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult(Female) |
|
Is the use of Intimacy Plus 0.03 mg/0.15 mg Tablet safe for pregnant women?
Intimacy Plus can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Intimacy Plus 0.03 mg/0.15 mg Tablet safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Intimacy Plus. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Intimacy Plus 0.03 mg/0.15 mg Tablet on the Kidneys?
Intimacy Plus may have mild side effects on the kidneys.
What is the effect of Intimacy Plus 0.03 mg/0.15 mg Tablet on the Liver?
Intimacy Plus may have severe effects on your liver, so do not take it without first consulting your doctor.
What is the effect of Intimacy Plus 0.03 mg/0.15 mg Tablet on the Heart?
Intimacy Plus has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Intimacy Plus 0.03 mg/0.15 mg Tablet unless your doctor advises you to do so -
Is this Intimacy Plus 0.03 mg/0.15 mg Tablet habit forming or addictive?
Forming a habit of Intimacy Plus 0.03 mg/0.15 mg Tablet has not been reported.
Interaction between Food and Intimacy Plus 0.03 mg/0.15 mg Tablet
There isn't any research available on the side effects of taking Intimacy Plus 0.03 mg/0.15 mg Tablet with food.
Interaction between Alcohol and Intimacy Plus 0.03 mg/0.15 mg Tablet
Due to lack of research, there is no information about the side effects of taking Intimacy Plus 0.03 mg/0.15 mg Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 318
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Desogen® (desogestrel and ethinyl estradiol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ortho-cept® (desogestrel and ethinyl estradiol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mircette® (desogestrel/ethinyl estradiol and ethinyl estradiol)